The Yale Center for Biomedical and Interventional Technology (CBIT) will lead a new $1 million seed grant program over two years from the Connecticut BioScience Innovation Fund to support commercialization of new biomedical ideas from Connecticut...
Yale’s Craig Crews leveraged basic science research that formed the basis of a cancer drug eventually valued at nearly $10 billion.Now Crews, the Lewis B. Cullman Professor of Molecular, Cellular and Developmental Biology and professor of chemistry and...